✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyLegalizationPatient AccessProduct SafetyState Regulation Why This MattersTennessee's potential cannabis legalization represents another state moving...
Inside fish models: 3.9 tons of cannabis resin thwarted at Tangier Med – Yabiladi.com
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Product SafetyIllicit CannabisThcPatient EducationDrug Policy Why This MattersThis interdiction highlights the persistent illegal cannabis...
Five Years Into New York Cannabis Legalization – High Times Magazine
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisPatient AccessProduct SafetyRegulation Why This MattersNew York's implementation challenges reflect broader patterns in...
Office of Cannabis Management issues consumer advisory for Tidal Wave brand vapes
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Product SafetyVaporizersRegulationQuality ControlPatient Safety Why This MattersProduct safety advisories highlight the persistent quality control...
State lawmakers advance bill to tighten rules on hemp-derived THC products – WACH Fox
WHY IT MATTERS: If South Carolina tightens rules on hemp-derived THC products, patients currently purchasing THC beverages, edibles, or tinctures from convenience stores or smoke shops may find those products reformulated, age-restricted, or removed from shelves entirely. CLINICAL OVERVIEW: South Carolina legislators are advancing a bill that would impose stricter regulations on hemp-derived THC products, including beverages and edibles that have proliferated since the 2018 Farm Bill created a legal gray area for these items. From a clinical perspective, the lack of standardized testing, dosing consistency, and labeling requirements for hemp-derived THC products has been a patient safety concern, as consumers often have no reliable way to know exactly what they are ingesting.